spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Valera Pharmaceuticals 

 HSMN NewsFeed - 7 Nov 2012
Insmed Appoints 15-Year Life Sciences Industry Veteran Andrew Drechsler as Chief Financial Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 29 Sep 2008
Oceana Therapeutics Commences Operations after Completing Series A Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Jun 2008
Indevus Announces Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Nov 2007
FDA Accepts New Drug Application for NEBIDO(R) Submitted by Indevus
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 28 Aug 2007
Indevus Announces Submission of New Drug Application
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 17 Aug 2007
Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 6 Aug 2007
Indevus Announces FDA Approval of SANCTURA(R) XR
Biopharmaceuticals Urology FDA
 HSMN NewsFeed - 29 Jun 2007
Indevus Appoints Industry Veteran Kurt Lewis as Senior Vice President Sales & Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jun 2007
Indevus Announces Launch of SUPPRELIN(R) LA for Central Precocious Puberty
Biopharmacceuticals
 HSMN NewsFeed - 21 Jun 2007
Elusys Names Jeremy D. Middleton Vice President of Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jun 2007
Indevus Reports Positive Data From Phase III NEBIDO(R) Trial
Biopharmaceuticals
 HSMN NewsFeed - 6 Jun 2007
Two Significant Hires Round-Out VaxInnate's Core Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 May 2007
Indevus Announces Authorization for Approval of VANTAS(R) in Selected European Countries
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 3 May 2007
Indevus Announces FDA Approval of SUPPRELIN(R)-LA
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Apr 2007
Indevus Announces Submission of Supplemental NDA to Reintroduce VALSTAR(R) to Treat Bladder Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Apr 2007
Indevus and Valera Announce Completion of Merger
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Mar 2007
Indevus Reports That Interim Review of NEBIDO(R) Phase III Data Indicates Trial Is Likely to Meet Primary Endpoints
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 12 Dec 2006
Indevus Pharmaceuticals to Acquire Valera Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 6 Nov 2006
Valera Pharmaceuticals Commences Clinical Studies of a Long-Acting Naltrexone Implant for Opioid Addiction
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 24 May 2006
Valera Pharmaceuticals Appoints Jeremy D. Middleton To The Position Of Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Apr 2006
Valera Pharmaceuticals Completes Phase III Study of Its Twelve-Month Implant for Treating Central Precocious Puberty
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 3 Apr 2006
Valera Pharmaceuticals Acquires Rights to VALSTAR
Biopharmaceuticals Urology Oncology Acquisitions
 HSMN NewsFeed - 14 Mar 2006
Valera Pharmaceuticals Announces Paladin Labs Receives Canadian Approval of VANTAS
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 14 Mar 2006
Health Canada Approves Vantas'R' for the Treatment of Advanced Prostate Cancer
Biopharmaceuticals Oncology Regulatory
Return to NewsFeed  

 Additional items found! 8

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 8 additional stories matching:
Valera Pharmaceuticals
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.